These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Genomic insights into intrinsic and acquired drug resistance mechanisms in Achromobacter xylosoxidans. Hu Y; Zhu Y; Ma Y; Liu F; Lu N; Yang X; Luan C; Yi Y; Zhu B Antimicrob Agents Chemother; 2015 Feb; 59(2):1152-61. PubMed ID: 25487802 [TBL] [Abstract][Full Text] [Related]
26. Longitudinal Surveillance and Combination Antimicrobial Susceptibility Testing of Multidrug-Resistant Okoliegbe IN; Hijazi K; Cooper K; Ironside C; Gould IM Antimicrob Agents Chemother; 2020 Oct; 64(11):. PubMed ID: 32816722 [No Abstract] [Full Text] [Related]
27. Presence of OXA-type enzymes in Achromobacter insuavis and A. dolens. Traglia G; Papalia M; Almuzara M; Gutkind G; Centrón D; Vay C; Radice M; Ramírez MS Curr Microbiol; 2014 Oct; 69(4):501-6. PubMed ID: 24894902 [TBL] [Abstract][Full Text] [Related]
28. Achromobacter xylosoxidans Bacteremia and Cellulitis: A Report of a Case. Dai J; Huen AO; Kestenbaum LA; Sarezky MD; Coughlin CC; Yan AC Pediatr Dermatol; 2015; 32(4):e186-7. PubMed ID: 25973735 [TBL] [Abstract][Full Text] [Related]
29. Achromobacter xylosoxidans respiratory tract infection in cystic fibrosis patients. Lambiase A; Catania MR; Del Pezzo M; Rossano F; Terlizzi V; Sepe A; Raia V Eur J Clin Microbiol Infect Dis; 2011 Aug; 30(8):973-80. PubMed ID: 21279730 [TBL] [Abstract][Full Text] [Related]
30. Epidemic Achromobacter xylosoxidans strain among Belgian cystic fibrosis patients and review of literature. Cools P; Ho E; Vranckx K; Schelstraete P; Wurth B; Franckx H; Ieven G; Van Simaey L; Van Daele S; Verhulst S; De Baets F; Vaneechoutte M BMC Microbiol; 2016 Jun; 16(1):122. PubMed ID: 27342812 [TBL] [Abstract][Full Text] [Related]
31. Epidemiology and resistance of Achromobacter xylosoxidans from cystic fibrosis patients in Dijon, Burgundy: first French data. Amoureux L; Bador J; Siebor E; Taillefumier N; Fanton A; Neuwirth C J Cyst Fibros; 2013 Mar; 12(2):170-6. PubMed ID: 22944724 [TBL] [Abstract][Full Text] [Related]
32. Mediastinitis superinfected by Achromobacter xylosoxidans. A case report. Marion-Sanchez K; Lion F; Olive C; Cailleaux G; Roques F J Infect Chemother; 2018 Dec; 24(12):987-989. PubMed ID: 29895453 [TBL] [Abstract][Full Text] [Related]
33. Fluorescence in situ hybridization for rapid identification of Achromobacter xylosoxidans and Alcaligenes faecalis recovered from cystic fibrosis patients. Wellinghausen N; Wirths B; Poppert S J Clin Microbiol; 2006 Sep; 44(9):3415-7. PubMed ID: 16954289 [TBL] [Abstract][Full Text] [Related]
34. Complicated intra-abdominal infection caused by extended drug-resistant Achromobacter xylosoxidans. Teng SO; Ou TY; Hsieh YC; Lee WC; Lin YC; Lee WS J Microbiol Immunol Infect; 2009 Apr; 42(2):176-80. PubMed ID: 19597652 [TBL] [Abstract][Full Text] [Related]